PLA2G4B antibody (AA 514-781)

Catalog No. ABIN7149404

Product Details anti-PLA2G4B Antibody

Target: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Binding Specificity: AA 514-781

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This PLA2G4B antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Cytosolic phospholipase A2 beta protein (514-781AA)

Isotype: IgG

Application Details

Application Notes: Recommended dilution: WB:1:1000-1:5000, IHC:1:200-1:500, IF:1:50-1:200,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for PLA2G4B

Target: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Alternative Name: PLA2G4B (PLA2G4B Products)

Synonyms: HsT16992 antibody, cPLA2-beta antibody, A030011C02Rik antibody, Gm1013 antibody, phospholipase A2 group IVB antibody, phospholipase A2, group IVB (cytosolic) antibody, PLA2G4B antibody, Pla2g4b antibody

Background:

Background: Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position with a preference for arachidonoyl phospholipids. Has a much weaker activity than PLA2G4A. Isoform 3 has calcium-dependent activity against palmitoyl-arachidonyl-phosphatidylethanolamine and low level lysophospholipase activity but no activity against phosphatidylcholine. Isoform 5 does have activity against phosphatidylcholine.

Aliases: PLA2G4B antibody, Cytosolic phospholipase A2 beta antibody, cPLA2-beta antibody, EC 3.1.1.4 antibody, Phospholipase A2 group IVB antibody

UniProt: P0C869

Pathways: ER-Nucleus Signaling, VEGF Signaling